← Open Payments lookup

MARTA HESHELMAN: Open Payments

NPI 1730540592 · BLOOMINGTON, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,177 in 65 payments from 23 companies in 2025. Trend: 2023 $518 · 2024 $937 · 2025 $1,177

Food & beverage: $1,177
CompanyPaymentsAmount
Novo Nordisk Inc15$184
Verona Pharma, Inc.8$158
Novartis Pharmaceuticals Corporation8$143
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)4$87
Azurity Pharmaceuticals, Inc.3$64
ABBVIE INC.3$57
AstraZeneca Pharmaceuticals LP3$51
VERTEX PHARMACEUTICALS INCORPORATED2$49
Stryker Corporation1$46
UCB, Inc.2$43

Products named: Ohtuvayre, LEQVIO, CAPLYTA, Ozempic, HORIZANT, JOURNAVX, ORTHOLOC 2 LAPIFUSE, VRAYLAR.

Industry payments across IN — which companies pay providers there.